Skip to main content
Jason Hirschhorn

Jason Hirschhorn

Principal

Industry expertise

  • Financial Services

  • Life Sciences

  • Nonprofit

  • Technology

View Full Team

Do not let what you cannot do interfere with what you can do.
- John Wooden

Jason is passionate about helping life sciences clients make progress on strategy, technology, organizational and operational challenges to better serve patients. Over his 20-year consulting career, Jason has led both planning and implementation initiatives and focusses on leading with curiosity, empathy and expertise to drive results collaboratively with clients.   

Jason has experience leading consulting teams in life sciences in commercial business operations, digital transformation, regulatory, informatics and clinical operations. He has experience with AI driven transformation, large scale process and organizational redesign and technology strategy and implementation efforts.  

Prior to Acquis, Jason was a Director and Senior Client Partner at Point B where he was responsible for managing a life sciences client portfolio. Jason also worked as a Manager at Deloitte where he served clients across industries on strategy and organizational transformation. He also spent time at FSG, a social impact strategy consulting firm. Earlier in his career, Jason was an 8th grade English teacher at a charter school in Boston.  

Jason holds an MBA from the Haas School of Business at UC Berkeley and a BA in Economics and English from Bates College. In his spare time, he enjoys basketball, finding good new spots to eat in the Bay Area and watching his kids become who they are.  

Insights by Jason Hirschhorn

  • Two people in suits examine a tablet. A digital brain projection appears behind them, surrounded by data graphics, in a dimly lit setting.
    Article

    AI Is the Answer, But to What Question?

    AI can accelerate life sciences, but only if operating models evolve with it. Five dimensions define whether AI is embedded structurally or stays a pilot.

    Read More

  • A person holding a tablet inspects servers in a dimly lit data center, with glowing lights on the equipment.
    Article

    An Industry in Transition: Early Signals Shaping Life Sciences in 2026

    At the end of 2025, we were closely monitoring three trends we believed would shape the next phase of biopharma’s operating model changes in 2026: data pipelines, the role of AI in due diligence, and the next-generation value chain. The J.P. Morgan Healthcare Conference offered the first opportunity to pressure-test those assumptions.

    Read More

Related Team Members